Pablo C.
- Country
- Spain
- Department
- Psychiatry
Research Overview
Data & Insights
Has run more than one trial at 0 of 72 partner sites.
Specializations
Psychiatric Care
This investigator specializes in treating Major Depressive Disorder (MDD), with particular emphasis on patients experiencing moderate-to-severe anhedonia. Their clinical research focuses on innovative therapeutic approaches for managing depressive symptoms.
- Depression Management
- Anhedonia Treatment
- Antidepressant Therapy
The investigator explores adjunctive treatment strategies to enhance therapeutic outcomes in depression care.
Treatment Resistance
Their expertise extends to addressing treatment-resistant depression through combination therapy approaches. The investigator studies the integration of novel therapeutic agents with established antidepressant medications.
- Combination Therapy
- Relapse Prevention
- Long-term Management
The focus includes developing strategies for maintaining stable treatment response in depression patients.
Clinical Innovation
The investigator specializes in evaluating novel therapeutic compounds for depression treatment. Their work encompasses the study of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in combination with emerging treatments.
- Therapeutic Innovation
- Drug Development
- Treatment Optimization
Their research aims to advance treatment options for patients with complex depressive disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.